References
1. Smetnik VP, Tumilovich L. G. Non-operative gynecology. Saint Petersburg: SOTIS, 1995. (in Russian)
2. Kostava M.N. Dystrophic diseases of the vulva. Diseases of the cervix, vagina and vulva. Edit. by V.N. Prilepskaya. Моscow: MEDpress, 1999: 326-36. (in Russian)
3. Forcucci-Zulli M., Gaglione R., et al. Sex steroid receptors in normal and malignant human vulvar tissue. Gynecol Obstet Invest. 1985; 19 (2): 103-6.
4. Garau J.M., Paola G.R., Charreau E.N. Estrogen and progesterone receptors assays on the vulvar epitelium. J Reprod Med. 1986; 31 (10): 987-91.
5. Hodgins M.B., Spike R.C., et al. Immunohistochemical investigation of androgen, estrogen and progesterone receptors in vulva and vagina. Br J Obstet Gynecol. 1998; 105 (2): 216-22.
6. MacLean A.B., Nicol L.A., Hodgins M.B. Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med. 1990; 35 (11): 1015-6.
7. Omsjo I.H., Wright P.B., Bormer O.P. Estrogen and progesterone receptors in normal and malignant vulvar tissue. Gynecol Obstet Invest. 1984; 17 (6): 281-3.
8. Steroid hormone receptors in human tumors. Edited by A.S. Bas-salyk. Moscow: Meditsina, 1987.
9. Balan V.E. Urogenital disorders in menopause (clinic, diagnosis, hormone replacement therapy). Autoabstract of Diss. Moscow, 1998. (in Russian)
10. Utian W.H. The place of oestriol therapy after menopause. Acta Endocrinol Suppl. (Copenh). 1980; 233: 51-6.
11. Bachman G.A., Notelovitz M. Long-term non hormonal treatment of vaginal dryness. Maturitas. 1995; 22: 1-5.
12. Fruchter R., Melnick L., Pomeranz M.K. Lichenoid vulvar disease: a review. Int J Womens Dermatol. 2017; 3 (1): 58-64.
13. Prilepskaya V.N., Smetnik V.P. The power of the fourth generation. StatusPraesens. Ginekologiya, akusherstvo, besplodnyy brak [StatusPraesens. Gynecology, Obstetrics, Barren Marriage]. 2019. № 2 (4): 29-35.2019; 2 (4): 29-35. (in Russian)
14. Ashrafyan L.A., Antonova I.B., Basova I.O., Babaeva N.A. Cancer of the vulva, endometrium, postmenopausal ovaries. Opukholi zhenskoy reproduktivnoy sistemy [Tumors of Female Reproductive System]. 2007; (4): 72-8. (in Russian)
15. Ashrafyan L.A., Kharchenko N.V., Akopova N.B., Ivashina S.V. Four pathogenetic variants of changes in the genitals in women in menopause.. Klimakteriy [Menopause]. 2001; (3): 7. (in Russian)
16. Ashrafyan L.A., Kharchenko N.V., Babaeva N.A., et al. The state of the receptor apparatus of the vulva with sclerotic lichen.Vestnik RUDN [Bulletin of Russian Peoples' Friendship University]. 2006; (1): 88-94. (in Russian)
17. Clark J.H., Paszko Z. Nuklear binding and retention of the receptor estrogen complex: relation the agonistic and antagonistic properties of estriol. Endocrinology. 1997; 100 (1): 91-6.
18. Press M.F., Nousek-Goebl N.A., Bur M. Estrogen receptors localization in the female genital tract. Am J Pathol. 1986; 123: 28092.
19. Serov V.N., Abubakirova A.M., Baranov I.I. Efferent treatments for pathological conditions in obstetrics Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 1997; (5): 64. (in Russian)
20. Bershtein LM. Hormonal carcinogenesis. St. Petersburg, 2000: 133-8. (in Russian)
21. Smetnik V.P. Systemic changes in women in menopause. Russkiy meditsinskiy zhurnal [Russian Medical Journal]. 2001; 9 (9): 354-7. (in Russian)
22. Becagli L., Scrimin F., De Salva D., et al. Hormone receptors in dystrophic and neoplastic vulvar disease. Preliminary consideration. Clin Exp Obstet Gynecol. 1983; 23: 145-9.
23. Nappi R.E., Murina F., Perrone G., Villa P., et al. Clinical profile of women with vulvar and vaginal atrophy who are not candidates for local vaginal estrogen therapy. Minerva Ginecol. 2017; 69 (4): 37080.
24. Cohen P.A., Anderson L., Eva L., Scurry J., et al. Clinical and molecular classification of vulvar squamous pre-cancers. Int J Gynecol Cancer. 2019; 29 (4): 821-8.
25. Ali E.S., Mangold C., Peiris A.N. Estriol: emerging clinical benefits. Menopause. 2017; 24 (9): 1081-5.